Jennison Associates’s Charles River Laboratories CRL Stock Holding History

Jennison Associates’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,169	Closed	-$526K	–	643
2020 Q1	$526K	Buy	+4,169	New	+$625K	﹤0.01%	562
2019 Q3	–	Sell	-9,295	Closed	-$1.32M	–	650
2019 Q2	$1.32M	Sell	9,295 -195	-2%	-$26.4K	﹤0.01%	525
2019 Q1	$1.38M	Buy	+9,490	New	+$1.25M	﹤0.01%	519
2017 Q4	–	Sell	-17,241	Closed	-$1.86M	–	653
2017 Q3	$1.86M	Buy	+17,241	New	+$1.77M	﹤0.01%	552
2015 Q4	–	Sell	-12,063	Closed	-$766K	–	676
2015 Q3	$766K	Sell	12,063 -106	-0.9%	-$7.61K	﹤0.01%	647
2015 Q2	$856K	Buy	+12,169	New	+$901K	﹤0.01%	686
2014 Q3	–	Sell	-9,685	Closed	-$518K	–	726
2014 Q2	$518K	Buy	+9,685	New	+$531K	﹤0.01%	686
2013 Q4	–	Sell	-6,037	Closed	-$279K	–	712
2013 Q3	$279K	Buy	+6,037	New	+$277K	﹤0.01%	679

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Jennison Associates's CRL Position: Q2 2020 in Review

Jennison Associates sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 4,169 shares — an estimated $526K sold.

Jennison Associates first reported a position in CRL in Q3 2013 and held it in 8 quarters. The position peaked at $1.86M in Q3 2017. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

Jennison Associates reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
Jennison Associates sold 4,169 Charles River Laboratories shares in Q2 2020, an estimated $526K.
Jennison Associates first reported a position in Charles River Laboratories in Q3 2013 and held it in 8 quarters.
Jennison Associates's Charles River Laboratories position peaked at $1.86M in Q3 2017.
466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Jennison Associates's 13F filing for Q2 2020, filed 6 Aug 2020.